Factors Associated with Surgical Site Infection in Pediatric Patients Undergoing Minimally Invasive Surgery for Congenital Heart Disease at the Cardiovascular Center, E Hospital, in 2025
Main Article Content
Abstract
Surgical site infection (SSI) is a notable complication following congenital heart surgery in pediatric patients, which may prolong hospital stay, increase treatment costs, and negatively affect recovery outcomes. Minimally invasive cardiac surgery via the right axillary approach has been increasingly adopted due to its advantages, including reduced tissue trauma, shorter recovery time, and improved cosmetic outcomes. However, SSIs may still occur and are influenced by various clinical and postoperative care–related factors.
Objective: To describe the incidence of surgical site infection and explore factors associated with SSI in pediatric patients undergoing minimally invasive surgery for congenital heart disease at the Cardiovascular Center – E Hospital in 2025.
Methods: A prospective descriptive study was conducted on 111 pediatric patients aged ≤15 years who underwent minimally invasive cardiac surgery via the right axillary approach at the Cardiovascular Center – E Hospital from February to August 2025. Data were collected from medical records and postoperative clinical follow-up. Associations between variables and SSI were analyzed using Fisher’s exact test. Odds ratios (ORs) with 95% confidence intervals (95% CI) were calculated.
Results: The overall SSI rate was 5.41% (6/111 cases), and all cases were classified as superficial SSIs; no cases of deep incisional or organ/space infections were recorded. Univariate analysis showed that factors associated with SSI included complex congenital heart disease (p = 0.035), operative duration ≥180 minutes (p = 0.027), and postoperative hypoxemia with SpO₂ <92% (OR = 11.3; p = 0.009).
Conclusion: The incidence of surgical site infection after minimally invasive cardiac surgery in pediatric patients at the Cardiovascular Center – E Hospital was relatively low and mainly consisted of superficial infections. However, the complexity of congenital heart disease, prolonged operative duration, and postoperative hypoxemia were statistically associated with SSI and may suggest a potential role in its risk. Close monitoring and optimization of postoperative care, particularly the maintenance of adequate tissue oxygenation, play an important role in preventing this complication.
Keywords
Surgical site infection, minimally invasive surgery, congenital heart disease, pediatric patients, associated factors
Article Details
References
2. Baird CW, Myers PO, Pizarro C. Innovation in congenital heart surgery. Front Pediatr. 2015;3:71.
3. Bacha E, Kalfa D. Minimally invasive paediatric cardiac surgery. Nat Rev Cardiol. 2014;11(1):24–34.
4. Liu G, Qiao J, Kou L, et al. Right vertical infra-axillary thoracotomy for correction of congenital heart defects. Ann Thorac Surg. 2010;90(5):1614–1619.
5. Do AT, Nguyen BP, Nguyen HTD. Kết quả phẫu thuật ít xâm lấn điều trị bệnh tim bẩm sinh. Tạp chí Y học Việt Nam. 2020;487(2):15–22.
6. Bộ Y tế. Hướng dẫn phòng ngừa nhiễm khuẩn vết mổ (Quyết định 3671/QĐ-BYT ngày 27/9/2012). Hà Nội: Bộ Y tế; 2012.
7. Sochet AA, Cartron AM, Nyhan A, et al. Surgical site infection after pediatric cardiothoracic surgery: impact on hospital cost and length of stay. World J Pediatr Congenit Heart Surg. 2017;8(1):7–12.
8. Costello JM, Graham DA, Morrow DF, et al. Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg. 2010;89(6):1833–1842.
9. Alshaya MA, Almutairi NS, Shaath GA, et al. Surgical site infections following pediatric cardiac surgery: rate and risk factors. J Saudi Heart Assoc. 2021;33(1):1–8.
10. World Health Organization. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization; 2006.
11. Vũ Hùng Vương. Nghiên cứu căn nguyên vi khuẩn và một số yếu tố liên quan đến nhiễm khuẩn vết mổ sau mổ tim trẻ em. Luận văn Bác sĩ chuyên khoa II. Hà Nội: Trường Đại học Y Hà Nội; 2012.
12. Nguyễn Quốc Anh, Nguyễn Việt Hùng, Phạm Ngọc Trường. Tỷ lệ mới mắc và yếu tố nguy cơ nhiễm khuẩn vết mổ tại một số bệnh viện của Việt Nam. Tạp chí Y học Thực hành. 2012;830(7):28–32.
13. Trần Thị Kim Oanh. Một số yếu tố liên quan đến nhiễm khuẩn vết mổ ở bệnh nhi sau phẫu thuật tim tại Trung tâm Tim mạch – Bệnh viện E. Luận văn Thạc sĩ Điều dưỡng. Hà Nội: Trường Đại học Y Hà Nội; 2022.
14. Harder EE, Gaies MG, Yu S, et al. Risk factors for surgical site infection in pediatric cardiac surgery patients undergoing delayed sternal closure. J Thorac Cardiovasc Surg. 2013;146(2):326–333.
15. Barker GM, O’Brien SM, Welke KF, et al. Major infection after pediatric cardiac surgery: a risk estimation model. Ann Thorac Surg. 2010;89(3):843–850.
16. Jha P, Woodward CS, Gardner H, Brown LS, Sanyal A, Karamlou T, et al. A quality improvement initiative to reduce surgical site infections after pediatric cardiac surgery. Pediatr Cardiol. 2020;41(7): 1402–1407. doi:10.1007/s00246-020-02396-x.
17. Leaper DJ, Edmiston CE. World Health Organization: global guidelines for the prevention of surgical site infection. J Hosp Infect. 2017;95(2):135–136.
18. Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784–791. doi:10.1001/jamasurg.2017.0904.
19. Gaies M, Cooper DS, Tabbutt S, DiNardo JA, Hirsch JC, Thiagarajan RR, et al. Perioperative management in pediatric and congenital cardiac surgery: a scientific statement from the American Heart Association. Circulation. 2019;139(24):e1159–e1191.
20. Chau N, Tran C, Clarke M, Kilburn J, St George-Hyslop C, Young D, et al. Pediatric cardiac surgical site infections: a quality improvement initiative. JTCVS Open. 2024;22:438–447. doi:10.1016/j.xjon.2024.08.013.
21. Suvorov VV, Ivanov DO. Risk factors for surgical site infection after cardiac surgery in neonates: a case-control study. J Clin Med. 2024;13(24):7755. doi:10.3390/jcm13247755.